Lucidi Bruno
SEC CIK 1829622 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Dir | 142.3K | — | — | 3 | 2024-06-16 | 2026-06-18 |
Most active insiders at AVIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Murphy Polly A. | Dir | $25.4K | — |
| 2 | Adams Jerome M. | Dir | — | — |
| 3 | Hammond Janet MJ | Chief Development Off | — | — |
| 4 | Vavricka John | Chief Commercial Off | — | — |
| 5 | Lucidi Bruno | Dir | — | — |
| 6 | Horga Maria Arantxa | Chief Medical Off | — | — |
| 7 | Foster Wayne | EVP, CAO | — | — |
| 8 | Polsky Bruce | Dir | — | — |
| 9 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 10 | Corcoran Andrea | See Remarks | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Atea Pharmaceuticals, Inc. | Lucidi Bruno | Dir | M - OptEx | $0.00 | +29.6K | 142.3K | +26% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | Atea Pharmaceuticals, Inc. | Lucidi Bruno | Dir | M - OptEx | $0.00 | +29.6K | 112.8K | +36% | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Atea Pharmaceuticals, Inc. | Lucidi Bruno | Dir | M - OptEx | $0.00 | +33.1K | 83.2K | +66% | $0 |
Purchase Sale Sale after option exercise All abbreviations